Natural killer T cell-based cancer immunotherapy.
van der Vliet
Hans J J
HJ
Cancer Biology Program, Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115, USA.
Balk
Steven P
SP
Exley
Mark A
MA
D017321:Clinical Trials, Phase I as Topic; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007694:Killer Cells, Natural / Q000276:immunology*; D017710:Lymphocyte Transfusion / Q000009:adverse effects; D009369:Neoplasms / Q000628:therapy*